Literature DB >> 19249768

Noninvasive measurement of oxygen saturation of the microvascular blood in Barrett's dysplasia by use of optical spectroscopy.

Arjen Amelink1, Jelle Haringsma, Henricus J C M Sterenborg.   

Abstract

BACKGROUND: Current investigations into endoscopic screening for the early detection of Barrett's esophageal adenocarcinoma have focused on visualization of the microvascular morphology by using narrow-band imaging (NBI). Adjustment of the center wavelength, particularly of the NBI blue imaging filter, may lead to improved image contrast, depending on the oxygen saturation of the microvascular blood of dysplastic and early cancerous Barrett's mucosa.
OBJECTIVE: To perform in vivo, noninvasive measurements of the oxygen saturation of the microvascular blood for different pathologic grades of Barrett's mucosa by using differential path-length spectroscopy (DPS).
DESIGN: DPS measurements were made on normal (n = 7), low-grade dysplastic (n = 10), high-grade dysplastic (n = 7), and cancerous (n = 4) Barrett's mucosa by using a fiber-optic probe, and were correlated to the histologic outcome of biopsy specimens taken from the same location.
SETTING: Academic medical center. PATIENTS: Fifteen patients with Barrett's esophagus who were undergoing gastroscopy.
INTERVENTIONS: Biopsy specimens were taken from suspicious areas in the esophagus. MAIN OUTCOME MEASUREMENTS: The oxygen saturation of the microvascular blood of different pathologic grades of Barrett's mucosa was assessed.
RESULTS: The oxygen saturation of the microvascular blood remains high (approximately 90%) throughout the metaplasia-dysplasia-adenocarcinoma sequence. LIMITATION: The small number of patients.
CONCLUSIONS: The current NBI blue imaging filter, centered on the peak absorption of oxyhemoglobin (415 nm), is well chosen, and little improvement in image contrast is to be expected from changes in this center wavelength.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19249768     DOI: 10.1016/j.gie.2008.08.039

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  6 in total

1.  Scanning elastic scattering spectroscopy detects metastatic breast cancer in sentinel lymph nodes.

Authors:  Martin R Austwick; Benjamin Clark; Charles A Mosse; Kristie Johnson; D Wayne Chicken; Santosh K Somasundaram; Katherine W Calabro; Ying Zhu; Mary Falzon; Gabrijela Kocjan; Tom Fearn; Stephen G Bown; Irving J Bigio; Mohammed R S Keshtgar
Journal:  J Biomed Opt       Date:  2010 Jul-Aug       Impact factor: 3.170

2.  Coupled forward-adjoint Monte Carlo simulation of spatial-angular light fields to determine optical sensitivity in turbid media.

Authors:  Adam R Gardner; Carole K Hayakawa; Vasan Venugopalan
Journal:  J Biomed Opt       Date:  2014-06       Impact factor: 3.170

3.  Elastic scattering spectroscopy as an optical marker of inflammatory bowel disease activity and subtypes.

Authors:  Eladio Rodriguez-Diaz; Christopher Atkinson; Lisa I Jepeal; Adam Berg; Christopher S Huang; Sandra R Cerda; Michael J OʼBrien; Irving J Bigio; Francis A Farraye; Satish K Singh
Journal:  Inflamm Bowel Dis       Date:  2014-06       Impact factor: 5.325

4.  Endoscopic histological assessment of colonic polyps by using elastic scattering spectroscopy.

Authors:  Eladio Rodriguez-Diaz; Qin Huang; Sandra R Cerda; Michael J O'Brien; Irving J Bigio; Satish K Singh
Journal:  Gastrointest Endosc       Date:  2014-09-23       Impact factor: 9.427

5.  Ischemic heart disease, factor predisposing to Barrett's adenocarcinoma: A case control study.

Authors:  Panagiotis Tsibouris; Mark T Hendrickse; Panagiota Mavrogianni; Peter Et Isaacs
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-08-06

6.  Investigation of the Possibility of Using Microspectrometers Based on CMOS Photodiode Arrays in Small-Sized Devices for Optical Diagnostics.

Authors:  Oleksandra Hotra; Vladimir Firago; Nikolay Levkovich; Konstantin Shuliko
Journal:  Sensors (Basel)       Date:  2022-05-31       Impact factor: 3.847

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.